Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD.

Int J Chron Obstruct Pulmon Dis · 2018 · PMC5846760 · PMID 29563781

Europe PMC DOI

hedged sentence

0.1140

closest p · 2.3× alpha

0.1140

boldest claim

The sentences

did not reach statistical significancep =0.114not close (p > 0.1)

There were fewer treatment discontinuations in the ROF 500 μg EOD/500 μg OD group compared with the ROF 500 μg OD group, but this difference did not reach statistical significance (20.1% versus 24.6%; RR 0.81 [95% CI 0.62–1.05], OR 0.76 [95% CI 0.55–1.07], p =0.114; Figure 2 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.